President's Dream Colloquium on Understanding Medical Marijuana
Cannabis and Pain Management
Speaker: Dr Mark Ware, MD
Dr. Mark Ware, MD
Associate Professor, Family Medicine and Anesthesia, McGill University, Director, Clinical Research, Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, PQ
Thursday, March 2, 2017, 4:00 – 5:30 pm,
Leslie & Gordon Diamond Family Auditorium
Convocation Mall, Burnaby campus
Major Sponsor: Aphria Inc.
Dr. Mark Ware is Associate Professor in Family Medicine and Anesthesia at McGill University. He is the Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre, co-Director of the Quebec Pain Research Network, and Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids (CCIC). He is a family physicians and practices pain medicine at the Montreal General Hospital and at the primary care pain clinic of the West Island of Montreal.
Dr Ware’s primary research interests are in evaluating the safety and effectiveness of medicines derived from cannabis (cannabinoids), population-based studies of the impact of pain on the population, and the role of complementary therapies in pain and symptom management. His research is funded by the FRSQ, CIHR, and the Louise and Alan Edwards Foundation.
A graduate of the University of the West Indies (MBBS 1992), Dr. Ware worked at the MRC Sickle Cell Unit in Kingston Jamaica from 1996-1998 where he developed his interests in pain management and cannabis therapeutics. He moved to McGill University in Montreal, Canada in 1999 and since then has secured the only two Canadian federal grants to study medical cannabis. He has published over 70 papers on pain and cannabis, 6 book chapters, and given over 150 scientific talks to local, national and international audiences. He has served as an advisor to the Canadian government since 2001 on medical cannabis policy, most recently as vice Chair of the Federal Task Force on the legalization and regulation of cannabis in Canada.
- Pain Expectation in Neuropathic Pain: Is It Best to Be Optimistic?
Co-authored by Bostick, G.P., Kamper, S.J., Moulin, D.E. et al | Article | October 2016 | European Journal of Pain
- Informing the Development of an Internet-Based Chronic Pain Self-Management Program
Co-authored by Gogovor, A., Visca, R., Ahmed, S. et al | Article | October 2016
- Effects of Topical Combinations of Clonidine and Pentoxifylline on Capsaicin-Induced Allodynia and Postcapsaicin Tourniquet-Induced Pain in Healthy Volunteers: A Double-Blind, Randomized, Controlled Study
Co-authored by Ragavendran, J.V., Laferriere, A., Coderre, T.J. et al | Article | July 2016 | Pain
- The Reciprocal Associations Between Catastrophizing and Pain Outcomes in Patients Being Treated for Neuropathic Pain: A Cross-Lagged Panel Analysis Study
Co-authored by Racine, M., Moulin, D.E., Jensen, M.P. et al | Article | April 2016 | Pain
- (540) iCanCope with Pain: User-Centered Design of an Integrated Smartphone and Web-Based Pain Self-Management Program for Youth and Young Adults with Chronic Pain
Co-authored by Stinson, J., Lalloo, C. et al | Article | April 2016